Amifostine, protects all of the following organs, EXCEPT:
**Core Concept**
Amifostine is a cytoprotective agent that provides radioprotection and chemoprotection by reducing the toxic effects of various chemotherapeutic agents and radiation on normal tissues. It works by inhibiting the uptake of platinum compounds in the kidneys and intestines, thereby reducing nephrotoxicity and enteritis.
**Why the Correct Answer is Right**
Amifostine protects the kidneys, intestines, and bone marrow from the toxic effects of chemotherapy and radiation. It does so by inhibiting the enzyme cytochrome P450 3A4 and reducing the concentration of chemotherapeutic agents in these organs. This results in a decrease in the incidence of nephrotoxicity, neutropenia, and mucositis.
**Why Each Wrong Option is Incorrect**
* **Option A:** Amifostine does not have a significant protective effect on the heart. While it may reduce the incidence of cardiac toxicity associated with anthracyclines, its primary mechanism is not cardioprotection.
* **Option B:** Amifostine does not protect the lungs from the toxic effects of chemotherapy and radiation. It may actually increase the risk of pulmonary toxicity in certain patients.
* **Option C:** Amifostine does not protect the liver from the toxic effects of chemotherapy and radiation. While it may reduce the incidence of hepatotoxicity associated with certain chemotherapeutic agents, its primary mechanism is not hepatoprotection.
**Clinical Pearl / High-Yield Fact**
Amifostine is most effective when administered before chemotherapy or radiation therapy to reduce the incidence of nephrotoxicity and enteritis. It is also used to reduce the incidence of xerostomia in patients undergoing radiation therapy for head and neck cancer.
**Correct Answer: A.**